HPLC purity
Target specification: ≥99% area purity by reverse-phase HPLC with UV detection; actual acceptance criteria and result are confirmed for the applicable product and lot.
Repair & recovery · worldwide
Lyophilized TB-500 (Thymosin Beta-4 active-site fragment) for qualified B2B research buyers, and private-label brand owners. ≥99% HPLC purity target, batch-linked COA, HPLC chromatogram and MS identity record. Often paired with BPC-157 in recovery protocols.
Vial illustrations reflect supplied lyophilized format. Lot codes are sample identifiers; production lots carry their own batch references.
| Compound | TB-500 (Thymosin Beta-4 fragment) |
|---|---|
| Active sequence | Leu-Lys-Lys-Thr-Glu-Thr-Gln-NH₂ (Ac-SDKP related actin-binding region) |
| Molecular weight | Confirmed against available documentation for the applicable product, specification and lot |
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 2 mg, 5 mg, 10 mg |
| Documentation | Batch-document availability confirmed by product, specification and applicable lot |
| Storage | 2–8 °C protected from light; long-term −20 °C |
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | 1 kit (10 vials) | 3–7 days |
| Production lot | 200–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
TB-500 and BPC-157 are frequently requested together for comparative research procurement. Add both to the Quote Cart for a coordinated reply.
Documentation
COA, HPLC chromatogram, MS identity confirmation, water content and storage notes. Buyer track and destination confirmed before invoicing.
Target specification: ≥99% area purity by reverse-phase HPLC with UV detection; actual acceptance criteria and result are confirmed for the applicable product and lot.
Mass spectrometry identity confirmation against the TB-500 reference profile.
Lot code printed on vial label and reflected in the document pack. Reorders cite the prior lot for continuity.
FAQ
TB-500 is the active fragment of Thymosin Beta-4, studied for cytoskeletal remodeling, cell migration and tissue recovery. Qualified B2B buyers and research organizations source TB-500 alongside BPC-157 in recovery protocols.
The combined repair / regeneration coverage is broader: BPC-157 focuses on angiogenesis and inflammation pathways, TB-500 on actin/cytoskeletal remodeling. Research organizations frequently quote both together.
Sample lots from 1 kit (10 vials); production lots from 200 vials with tier pricing.
Yes. For the applicable lot, Pepti confirms the available document set during RFQ review. Depending on the product and lot, the set can include a Certificate of Analysis showing HPLC purity, MS identity, water content and lot traceability.
Yes. Neutral or branded vial labels, carton design, document packs and lot-code handling are available — see the OEM service path.
Related compounds
Current Batch COA
Batch-linked COA PDF for each TB-500 specification below, with the reported chromatographic purity and molecular-weight identity results. Independent local verification is welcome. Confirmed quality issues are eligible for replacement or refund under the quality policy.